Weili Zhao
-
- Lymphoma Diagnosis and Treatment 39
- Oncology top 10%
- CAR-T cell therapy research 11
- Viral-associated cancers and disorders 7
- Immunology top 10%
- Immune Cell Function and Interaction 9
- Hematology top 10%
- Cancer Research top 10%
-
- Chronic Lymphocytic Leukemia Research 14
-
- Lung Cancer Treatments and Mutations 7
-
- Acute Lymphoblastic Leukemia research 6
-
- Epigenetics and DNA Methylation 5
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)Blood (9 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Weili Zhao
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Pathology and Forensic Medicine 379
- Oncology 336
- Immunology 254
- Hematology 127
- Cancer Research 171
Countries citing papers authored by Weili Zhao
This map shows the geographic impact of Weili Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Zhao more than expected).
Fields of papers citing papers by Weili Zhao
This network shows the impact of papers produced by Weili Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Zhao. The network helps show where Weili Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weili Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 24 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 1 | |
| 9 | 2019 | 81 | |
| 10 | 2018 | 6 | |
| 11 | 2018 | 23 | |
| 12 | 2018 | 6 | |
| 13 | 2018 | 31 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2014 | 150 | |
| 17 | 2010 | 21 | |
| 18 | 2010 | 9 | |
| 19 | 2009 | 34 | |
| 20 | The research on the association of the ICAM-1 K469E gene polymorphism with multiple sclerosis in Han nationality of Henan | 2008 | 1 |
About Weili Zhao
Weili Zhao is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 73 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (39 papers), Chronic Lymphocytic Leukemia Research (14 papers), CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (9 papers), Viral-associated cancers and disorders (7 papers), Lung Cancer Treatments and Mutations (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (379 citations), Oncology (336 citations) and Immunology (254 citations). Weili Zhao has collaborated with scholars based in China, France and United States. Frequent co-authors include Li Wang, Anne Janin, Sai‐Juan Chen, Christophe Lebœuf, Zhixiang Shen, Di Fu, Junmin Li, Pengpeng Xu, Shu Cheng and Yan Zhao. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.